These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9570190)

  • 1. Effects of quinidine and verapamil on human cardiovascular alpha1-adrenoceptors.
    Shibata K; Hirasawa A; Foglar R; Ogawa S; Tsujimoto G
    Circulation; 1998 Apr; 97(13):1227-30. PubMed ID: 9570190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification.
    Ford AP; Daniels DV; Chang DJ; Gever JR; Jasper JR; Lesnick JD; Clarke DE
    Br J Pharmacol; 1997 Jul; 121(6):1127-35. PubMed ID: 9249248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha1-adrenergic receptor subtypes in human detrusor.
    Malloy BJ; Price DT; Price RR; Bienstock AM; Dole MK; Funk BL; Rudner XL; Richardson CD; Donatucci CF; Schwinn DA
    J Urol; 1998 Sep; 160(3 Pt 1):937-43. PubMed ID: 9720591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular alpha1-adrenoceptor subtypes: functions and signaling.
    Varma DR; Deng XF
    Can J Physiol Pharmacol; 2000 Apr; 78(4):267-92. PubMed ID: 10772055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction.
    Hampel C; Dolber PC; Smith MP; Savic SL; Th roff JW; Thor KB; Schwinn DA
    J Urol; 2002 Mar; 167(3):1513-21. PubMed ID: 11832780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinidine plus verapamil vs. quinidine alone to prevent recurrences of atrial fibrillation.
    Veloso HH; de Paola AA
    Eur Heart J; 2005 Aug; 26(15):1568-9. PubMed ID: 15899928
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
    Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
    Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antiarrhythmic activity of the polymeric forms of quinidine, trimecaine, etatsizin, propranolol and verapamil].
    Sidorenko GI; Gurin AV; Koliadko MG; Iurkshtovich TL; Nedorezov VL
    Eksp Klin Farmakol; 1993; 56(3):27-30. PubMed ID: 8219985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
    Gülker H; Bramann HU; Brisse B; Kuhs H
    Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History and nomenclature of alpha1-adrenoceptors.
    Langer SZ
    Eur Urol; 1999; 36 Suppl 1():2-6. PubMed ID: 10438241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine alpha1-adrenoceptor subtypes. I. Radioligand binding studies.
    Yang M; Reese J; Cotecchia S; Michel MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):841-7. PubMed ID: 9694940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
    Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pharmacology of human alpha1-adrenergic receptors: unique features of the alpha 1a-subtype.
    Schwinn DA; Price RR
    Eur Urol; 1999; 36 Suppl 1():7-10. PubMed ID: 10393466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of mexiletine as an antagonist of beta-adrenoceptor in Chinese hamster ovary cells expressing cloned human beta-adrenoceptors.
    Sakamoto K; Karikomi Y; Kubota Y; Nakahara T; Ishii K
    Biochem Pharmacol; 2004 Mar; 67(5):815-22. PubMed ID: 15104234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR; Hanna C
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha1-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels.
    Smith MS; Schambra UB; Wilson KH; Page SO; Schwinn DA
    Brain Res Mol Brain Res; 1999 Jan; 63(2):254-61. PubMed ID: 9878769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs and the heart. IV. Antiarrhythmic agents.
    Opie LH
    Lancet; 1980 Apr; 1(8173):861-8. PubMed ID: 6103220
    [No Abstract]   [Full Text] [Related]  

  • 20. History and nomenclature of alpha1-adrenoceptors.
    Langer SZ
    Eur Urol; 1999; 36 Suppl 1():2-6. PubMed ID: 10393465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.